Medplus Health Services Ltd
Medplus Health Services Q3 FY25 earnings call: Revenue & Margins
Q3 FY25 earnings call: what management guided on revenue, margins and order book.
The short version
Private label sales expected to grow by about 1% per quarter on MRP basis, adding 15-20 basis points to gross margin quarterly. MedPlus expects steady profitability levels with store-level EBITDA margins around 10-11%, sustainable over the next 2-3 years.
From Medplus Health Services Ltd's Q3 FY25 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Private label sales expected to grow by about 1% per quarter on MRP basis, adding 15-20 basis points to gross margin quarterly.
- Network expansion targeted at around 600 new stores annually starting FY '26, supporting sales growth.
- Store same-store sales growth (SSSG) aimed to be around 4-5%, with focus on market share and profitability rather than just sales growth.
- Total pharmacy GMV growth expected to be in line with typical pharma market growth plus inflation, around low double digits (15-16% sales growth combining store addition and SSSG).
- Gross margins expected to improve modestly with private label penetration increasing from current ~68% to ~75-77% of products.
2 more points from Medplus Health Services Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Medplus Health Services Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- MedPlus is investing in strengthening its backend operations and infrastructure for long-term scalability and seamless execution.
- Four new warehouses have been added recently to enhance availability at existing stores and support new store openings.
- Additional warehouses planned: Hubli, Madurai, Agra (2), Vijayawada, Vizag, Kapai, Nagpur, Raipur, and Indore, totaling about 10 smaller warehouses (30,000 to 50,000 sq. ft. each).
- These warehouses aim to improve supply chain efficiency, better serve current stores, and enable faster expansion into new areas and states.
2 more points from Medplus Health Services Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Fundraising & Capital Structure
See what Medplus Health Services Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Medplus Health Services Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Medplus Health Services Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹1.9K Cr, net profit ₹64 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Medplus Health's management said in earlier quarters
Others in Retailing this season
- Just Dial (Q3 FY25)
Operating Revenue for 3Q FY25: ₹2,873 million, up 8.4% YoY from ₹2,650 million in 3Q FY24. Key concall takeaways from Just Dial Ltd's Q3 FY25 earnings call…
- Trent Ltd (Q3 FY25)
Q3 FY25 consolidated revenue: ₹4,657 Cr (Page 5) . Key concall takeaways from Trent Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.
- Macfos (Q3 FY25)
Q3 FY25 revenue: ₹46.67 crore, up 48% compared to Q3 FY24 (₹31.58 crore or 3158.37 lakhs). Key concall takeaways from Macfos Ltd's Q3 FY25 earnings call — and…
- Matrimony.com Ltd (Q3 FY25)
Industry-wide 8% drop in search queries impacting profile registration. Key concall takeaways from Matrimony.com Ltd's Q3 FY25 earnings call — and how it ranks…
Arthneeti Pro · Annual
Medplus Health Services Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Medplus Health Services Ltd Q3 FY25 results?
Private label sales expected to grow by about 1% per quarter on MRP basis, adding 15-20 basis points to gross margin quarterly. MedPlus expects steady profitability levels with store-level EBITDA margins around 10-11%, sustainable over the next 2-3 years.
What is Medplus Health Services Ltd share price analysis?
Medplus Health Services Ltd currently shows a neutral. The stock trades at a P/E of 39.4 with a market cap of ₹8,293 Cr. Investors should review the full earnings analysis for detailed insights.
Is Medplus Health Services Ltd planning capital expenditure?
MedPlus is investing in strengthening its backend operations and infrastructure for long-term scalability and seamless execution.
Keep Medplus Health Services Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.